国新健康(000503) - 2024 Q2 - 季度业绩预告

Financial Performance - The company expects a net loss attributable to shareholders of approximately -75.82 million yuan for the first half of 2024, a decrease in loss of 11% compared to -84.95 million yuan in the same period last year [6]. - The net profit after deducting non-recurring gains and losses is estimated to be -81.40 million yuan, compared to -90.69 million yuan in the previous year [6]. - The basic earnings per share is projected to be -0.0774 yuan, an improvement from -0.0937 yuan per share in the same period last year [6]. Business Strategy - The company is focusing on enhancing its digital health insurance services and accelerating investments in digital healthcare and pharmaceuticals [7]. - The overall business shows a seasonal characteristic of lower performance at the beginning of the period and higher performance towards the end [7]. Financial Reporting - The financial data in the earnings forecast has not been audited by registered accountants [7]. - The specific financial data for the first half of 2024 will be disclosed in detail in the half-year report [7].